|
⚲
|
| Nanomedex Pharmaceuticals Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001448282 |
| Sale | 2009-05-19 ($0.5 M Offered, $0.5 M Sold) |
| Fund | |
| Phone | 6088779933 |
| Address | 5520 Nobel Drive Fitchburg, 53711 |
| Source | [EDGAR] |
| Fund AUM and Sold ($k) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| David Cooper | |
| Timothy Morey | |
| Kenneth Johnson | |
| Jeffrey Girard | |
| Nikolaus Gravenstein | |
| Mark Nottoli |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Investcorp-Tages Impact Fund, a compartment of Investcorp-Ta
✚
|
0.0 | |
|
Investcorp Technology Partners V-B, L.P.
✚
|
0.0 | |
|
Investination LP Series A
✚
|
0.0 | |
|
Investindustrial VII L.P.
✚
|
0.0 | |
|
Investor Cash Management Holdings, Inc.
✚
|
0.0 | |
|
Investors Real Estate Trust
✚
|
0.0 | |
|
Investure PE Fund, LP - Series 4
✚
|
0.0 | |
|
Investx Series BM-1 A Series of Investx Master LLC
✚
|
0.0 | |
|
InvestX Series (HS), A Series of InvestX Master LLC
✚
|
0.0 | |
|
Investcorp Securities Limited
✚
|
0.0 |